Canopy Growth Corporation (NYSE:CGC) is reporting second quarter financial results on Monday 9th November 2020, before market open.
Previous Quarter Performance
Canopy Growth Corporation unfold loss for the first quarter of $ 0.19 per share, from the revenue of $ 85.90 million.
Stock Performance
On Friday, shares of Canopy Growth Corporation has traded high as $ 24.98 and has cracked $ 21.90 on the downward trend, reaching $ 23.50 with volume of 34.15 million shares.
According to the previous trading day, closing price of $ 23.50, representing a 135.56 % increase from the 52 week low of $ 9.00 and a 18.37 % decrease over the 52 week high of $ 25.97.
The company has a market capital of $ 8.68 billion and is part of the Healthcare sector and Drug Manufacturers – Specialty & Generic industry.
Conference Call
Canopy Growth Corporation will be hosting a conference call at 10:00 AM eastern time on 9th November 2020, to discuss its 2Q21 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.canopygrowth.com
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names.
